EFTR vs. CLVR, ONCSQ, PXMD, ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, and BFRIW
Should you be buying eFFECTOR Therapeutics stock or one of its competitors? The main competitors of eFFECTOR Therapeutics include Clever Leaves (CLVR), OncoSec Medical (ONCSQ), PaxMedica (PXMD), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.
eFFECTOR Therapeutics vs. Its Competitors
Clever Leaves (NASDAQ:CLVR) and eFFECTOR Therapeutics (NASDAQ:EFTR) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, media sentiment, community ranking, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends.
Clever Leaves has a beta of 3516.09, indicating that its share price is 351,509% more volatile than the S&P 500. Comparatively, eFFECTOR Therapeutics has a beta of 0.22, indicating that its share price is 78% less volatile than the S&P 500.
6.9% of Clever Leaves shares are held by institutional investors. Comparatively, 57.7% of eFFECTOR Therapeutics shares are held by institutional investors. 8.2% of Clever Leaves shares are held by company insiders. Comparatively, 4.7% of eFFECTOR Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
eFFECTOR Therapeutics received 10 more outperform votes than Clever Leaves when rated by MarketBeat users. However, 81.25% of users gave Clever Leaves an outperform vote while only 79.31% of users gave eFFECTOR Therapeutics an outperform vote.
Clever Leaves has higher revenue and earnings than eFFECTOR Therapeutics. Clever Leaves is trading at a lower price-to-earnings ratio than eFFECTOR Therapeutics, indicating that it is currently the more affordable of the two stocks.
In the previous week, Clever Leaves' average media sentiment score of 0.00 equaled eFFECTOR Therapeutics'average media sentiment score.
Summary
Clever Leaves beats eFFECTOR Therapeutics on 6 of the 10 factors compared between the two stocks.
Get eFFECTOR Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for EFTR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding EFTR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
eFFECTOR Therapeutics Competitors List
Related Companies and Tools
This page (NASDAQ:EFTR) was last updated on 6/15/2025 by MarketBeat.com Staff
Buy EFTR Stock Free EFTR Stock Alerts